<DOC>
	<DOC>NCT03082560</DOC>
	<brief_summary>The study's Primary Objective is to design and validate a grading system for objective and accurate assessment of lichen planopilaris. Secondary Objectives: - To assess change in symptoms such as pain and itch using a Numeric Rating Scale(NRS) scores and quality of life using the Dermatology Life Quality Index (DLQI) scores - To correlate this grading system with patient skin biopsies evaluating disease activity on a microscopic level - To correlate this grading system with digital global photography and trichoscopy</brief_summary>
	<brief_title>Design and Validation of a New Assessment Tool for Lichen Planopilaris</brief_title>
	<detailed_description />
	<mesh_term>Alopecia</mesh_term>
	<mesh_term>Lichen Planus</mesh_term>
	<criteria>1. Male or female subjects in general good health between the ages of 18 and 80 years old 2. Clinical and histologic diagnosis of lichen planopilaris 3. Subject is able to understand and sign informed consent 4. Subject is able to complete the study and comply with study procedures 5. Subject has no known allergy to nontoxic ink 6. Subjects should be managed by an Massachusetts General Hospital dermatologist for their lichen planopilaris for the duration of the study Eligible subjects will be excluded from participation if they meet any of the following criteria: 1. Presence of dermatoses that might interfere with LPP diagnosis and/or evaluation such as seborrheic dermatitis or psoriasis 2. Other selected concomitant causes of hair loss, including discoid lupus erythematosus, central centrifugal cicatricial alopecia (CCCA), telogen effluvium 3. Abnormal TSH laboratory value &gt;1 standard deviation above normal within last year 4. Any significant medical condition that may prevent the patient from participating in the study according to the investigator's assessment 5. Any known allergy to nontoxic ink Related to Biopsy 6. History of poor wound healing or bloodclotting abnormality 7. History of keloid formation or hypertrophic scarring 8. Regular intake of high doses of aspirin or anticoagulant medications 9. Hypersensitivity to local anesthetics 10. History of poorly controlled diabetes mellitus 11. Pregnant, nursing or planning a pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>